GP-GPT: Large Language Model for Gene-Phenotype Mapping

Read original: arXiv:2409.09825 - Published 9/17/2024 by Yanjun Lyu, Zihao Wu, Lu Zhang, Jing Zhang, Yiwei Li, Wei Ruan, Zhengliang Liu, Xiaowei Yu, Chao Cao, Tong Chen and 8 others
Total Score

0

💬

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • The paper introduces GP-GPT, a large language model for gene-phenotype mapping.
  • GP-GPT is trained on a large corpus of biomedical literature to learn the relationships between genes and their associated phenotypes.
  • The model can be used for tasks like predicting the phenotypic effects of genetic variants and generating human-readable summaries of gene-phenotype associations.

Plain English Explanation

GP-GPT: Large Language Model for Gene-Phenotype Mapping is a new artificial intelligence (AI) system that has been trained to understand the connections between genes and their associated physical characteristics or traits (called "phenotypes").

The researchers behind GP-GPT have created a large language model, which is a type of AI that can process and generate human-like text. They trained this model on a huge amount of biomedical literature, such as scientific papers and databases, that describe the relationships between different genes and the physical effects they can have.

By learning from all this data, GP-GPT has become very knowledgeable about gene-phenotype associations. It can now be used for a few key applications:

  1. Predicting phenotypic effects of genetic variants: If you give GP-GPT information about a genetic mutation or variant, it can predict what physical traits or characteristics that variant is likely to influence.

  2. Generating summaries of gene-phenotype links: GP-GPT can take complex scientific information about a gene and its phenotypic effects, and generate easy-to-understand written summaries explaining those connections.

The goal of GP-GPT is to help researchers, clinicians, and the general public better understand the connections between our genes and the physical traits they contribute to. This could be useful for medical applications like diagnosing and treating genetic disorders, as well as for basic biology research.

Technical Explanation

GP-GPT: Large Language Model for Gene-Phenotype Mapping presents a novel large language model architecture called GP-GPT that is trained to map genes to their associated phenotypes.

The researchers first constructed a large corpus of biomedical literature, including scientific papers, clinical notes, and online databases, that describe gene-phenotype relationships. They then used this corpus to train GP-GPT using standard language modeling techniques.

The key innovation of GP-GPT is its ability to learn complex associations between genes and phenotypes from the training data. Unlike previous rule-based or machine learning approaches, GP-GPT can capture nuanced, probabilistic relationships between genetic variants and their effects.

The paper evaluates GP-GPT on several benchmark tasks, including predicting phenotypic effects of genetic variants and generating natural language summaries of gene-phenotype links. The results demonstrate that GP-GPT outperforms previous state-of-the-art methods on these tasks, highlighting its potential as a powerful tool for biomedical research and clinical applications.

Critical Analysis

The GP-GPT paper presents a compelling approach to gene-phenotype mapping using large language models. However, there are a few potential limitations and areas for further research:

  1. Training data quality and bias: The performance of GP-GPT is heavily dependent on the quality and comprehensiveness of the training data. Biases or gaps in the literature could lead to inaccuracies or blind spots in the model's gene-phenotype knowledge.

  2. Interpretability and explainability: As a large neural network, GP-GPT may struggle with interpretability - it may be difficult to understand the model's internal reasoning for its predictions and summaries. More work is needed to improve the transparency of these types of AI systems.

  3. Real-world clinical validation: While GP-GPT shows promise on benchmark tasks, its true utility will depend on rigorous validation in real-world clinical and research settings. Careful testing is required to ensure the model's outputs are reliable and actionable.

  4. Generalization to novel genes and phenotypes: The paper focuses on evaluating GP-GPT on known gene-phenotype associations. An important next step would be to assess the model's ability to accurately predict and reason about novel, unseen connections.

Overall, the GP-GPT paper represents an exciting advancement in the field of computational biology. However, further research and real-world validation will be crucial to realize the full potential of large language models for gene-phenotype mapping and related biomedical applications.

Conclusion

GP-GPT: Large Language Model for Gene-Phenotype Mapping introduces a novel large language model architecture that can effectively learn and reason about the complex connections between genes and their associated physical traits or phenotypes.

By training on a vast corpus of biomedical literature, GP-GPT has become a powerful tool for tasks like predicting the effects of genetic variants and generating human-readable summaries of gene-phenotype relationships. This technology has significant potential to advance biomedical research and clinical applications, from understanding genetic disorders to developing personalized treatments.

However, the paper also highlights the need for further research to address potential limitations around data bias, model interpretability, and real-world validation. As the field of AI-powered computational biology continues to evolve, systems like GP-GPT will play an increasingly important role in unlocking the secrets of the human genome and improving human health.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

💬

Total Score

0

New!GP-GPT: Large Language Model for Gene-Phenotype Mapping

Yanjun Lyu, Zihao Wu, Lu Zhang, Jing Zhang, Yiwei Li, Wei Ruan, Zhengliang Liu, Xiaowei Yu, Chao Cao, Tong Chen, Minheng Chen, Yan Zhuang, Xiang Li, Rongjie Liu, Chao Huang, Wentao Li, Tianming Liu, Dajiang Zhu

Pre-trained large language models(LLMs) have attracted increasing attention in biomedical domains due to their success in natural language processing. However, the complex traits and heterogeneity of multi-sources genomics data pose significant challenges when adapting these models to the bioinformatics and biomedical field. To address these challenges, we present GP-GPT, the first specialized large language model for genetic-phenotype knowledge representation and genomics relation analysis. Our model is fine-tuned in two stages on a comprehensive corpus composed of over 3,000,000 terms in genomics, proteomics, and medical genetics, derived from multiple large-scale validated datasets and scientific publications. GP-GPT demonstrates proficiency in accurately retrieving medical genetics information and performing common genomics analysis tasks, such as genomics information retrieval and relationship determination. Comparative experiments across domain-specific tasks reveal that GP-GPT outperforms state-of-the-art LLMs, including Llama2, Llama3 and GPT-4. These results highlight GP-GPT's potential to enhance genetic disease relation research and facilitate accurate and efficient analysis in the fields of genomics and medical genetics. Our investigation demonstrated the subtle changes of bio-factor entities' representations in the GP-GPT, which suggested the opportunities for the application of LLMs to advancing gene-phenotype research.

Read more

9/17/2024

PharmGPT: Domain-Specific Large Language Models for Bio-Pharmaceutical and Chemistry
Total Score

0

PharmGPT: Domain-Specific Large Language Models for Bio-Pharmaceutical and Chemistry

Linqing Chen, Weilei Wang, Zilong Bai, Peng Xu, Yan Fang, Jie Fang, Wentao Wu, Lizhi Zhou, Ruiji Zhang, Yubin Xia, Chaobo Xu, Ran Hu, Licong Xu, Qijun Cai, Haoran Hua, Jing Sun, Jin Liu, Tian Qiu, Haowen Liu, Meng Hu, Xiuwen Li, Fei Gao, Yufu Wang, Lin Tie, Chaochao Wang, Jianping Lu, Cheng Sun, Yixin Wang, Shengjie Yang, Yuancheng Li, Lu Jin, Lisha Zhang, Fu Bian, Zhongkai Ye, Lidong Pei, Changyang Tu

Large language models (LLMs) have revolutionized Natural Language Processing (NLP) by minimizing the need for complex feature engineering. However, the application of LLMs in specialized domains like biopharmaceuticals and chemistry remains largely unexplored. These fields are characterized by intricate terminologies, specialized knowledge, and a high demand for precision areas where general purpose LLMs often fall short. In this study, we introduce PharmaGPT, a suite of domain specilized LLMs with 13 billion and 70 billion parameters, specifically trained on a comprehensive corpus tailored to the Bio-Pharmaceutical and Chemical domains. Our evaluation shows that PharmaGPT surpasses existing general models on specific-domain benchmarks such as NAPLEX, demonstrating its exceptional capability in domain-specific tasks. Remarkably, this performance is achieved with a model that has only a fraction, sometimes just one-tenth-of the parameters of general-purpose large models. This advancement establishes a new benchmark for LLMs in the bio-pharmaceutical and chemical fields, addressing the existing gap in specialized language modeling. It also suggests a promising path for enhanced research and development, paving the way for more precise and effective NLP applications in these areas.

Read more

7/10/2024

High-Throughput Phenotyping of Clinical Text Using Large Language Models
Total Score

0

High-Throughput Phenotyping of Clinical Text Using Large Language Models

Daniel B. Hier, S. Ilyas Munzir, Anne Stahlfeld, Tayo Obafemi-Ajayi, Michael D. Carrithers

High-throughput phenotyping automates the mapping of patient signs to standardized ontology concepts and is essential for precision medicine. This study evaluates the automation of phenotyping of clinical summaries from the Online Mendelian Inheritance in Man (OMIM) database using large language models. Due to their rich phenotype data, these summaries can be surrogates for physician notes. We conduct a performance comparison of GPT-4 and GPT-3.5-Turbo. Our results indicate that GPT-4 surpasses GPT-3.5-Turbo in identifying, categorizing, and normalizing signs, achieving concordance with manual annotators comparable to inter-rater agreement. Despite some limitations in sign normalization, the extensive pre-training of GPT-4 results in high performance and generalizability across several phenotyping tasks while obviating the need for manually annotated training data. Large language models are expected to be the dominant method for automating high-throughput phenotyping of clinical text.

Read more

8/6/2024

💬

Total Score

0

ChiMed-GPT: A Chinese Medical Large Language Model with Full Training Regime and Better Alignment to Human Preferences

Yuanhe Tian, Ruyi Gan, Yan Song, Jiaxing Zhang, Yongdong Zhang

Recently, the increasing demand for superior medical services has highlighted the discrepancies in the medical infrastructure. With big data, especially texts, forming the foundation of medical services, there is an exigent need for effective natural language processing (NLP) solutions tailored to the healthcare domain. Conventional approaches leveraging pre-trained models present promising results in this domain and current large language models (LLMs) offer advanced foundation for medical text processing. However, most medical LLMs are trained only with supervised fine-tuning (SFT), even though it efficiently empowers LLMs to understand and respond to medical instructions but is ineffective in learning domain knowledge and aligning with human preference. In this work, we propose ChiMed-GPT, a new benchmark LLM designed explicitly for Chinese medical domain, and undergoes a comprehensive training regime with pre-training, SFT, and RLHF. Evaluations on tasks including information extraction, question answering, and dialogue generation demonstrate ChiMed-GPT's superior performance over general domain LLMs. Furthermore, we analyze possible biases through prompting ChiMed-GPT to perform attitude scales regarding discrimination of patients, so as to contribute to further responsible development of LLMs in the medical domain. The code and model are released at https://github.com/synlp/ChiMed-GPT.

Read more

7/17/2024